Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

As the world continues to experience the effects of SARS‐CoV‐2, there is evidence to
suggest that the sequelae of viral infection (the post‐COVID‐19 condition; PCC) at both an …

Background Recent numerous epidemiology and clinical association studies reported that
ApoE polymorphism might be associated with the risk and severity of coronavirus disease …

Background COVID-19 is associated with an increased risk of cardiovascular complications.
Although cytokines have a predominant role in endothelium damage, the precise molecular …

Introduction Individuals recovering from acute COVID‐19 episodes may continue to suffer
from various ongoing symptoms, collectively referred to as Long‐COVID. Long‐term pain …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the coronavirus disease 2019 (COVID-19). COVID-19 is now recognized as a multiorgan …

Background and purpose Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection can exacerbate previous headache disorders or change the type of pain …

A better understanding of biological and emotional variables associated with health-related
quality of life in people with long-COVID is needed. Our aim was to identify potential direct …

The renin-angiotensin system (RAS) is one of the biggest challenges of cardiovascular
medicine. The significance of the RAS in the chronic progression of SARS-CoV-2 infection …

SARS-CoV-2 has caused a global pandemic and an unprecedented public health crisis,
infecting more than 580 million people worldwide. Moreover, recent evidence has …